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ANATOMY DETERMINES ETIOLOGY IN THORACIC AORTIC ANEURYSM 
 
JOSHUA VAPNIK 
 
ABSTRACT 
 
Background 
It is well established that thoracic aortic aneurysms (TAA) and abdominal 
aortic aneurysms (AAA) have different risk factors, clinical features, and genetic 
influences. Differences between and amongst subtypes of TAAs have received 
less attention. Despite observations of divergent clinical outcomes between 
ascending thoracic aortic aneurysms (ATAAs) and descending thoracic aortic 
aneurysms (DTAAs), etiologic factors determining the anatomic distribution of 
these aneurysms are not well understood.  
 
Methods 
From 3,247 patients registered in an institutional Thoracic Aortic Center 
Database from July 1992 through August 2013, we identified 921 patients with 
full aortic dimensional imaging by CT or MRI scan with TAA > 3.5 cm and without 
evidence of aortic dissection (AoD). Patients were analyzed in three groups: 
isolated ATAA (n=677), isolated DTAA (n=97), and combined ATAA and DTAA 
(n=146).  
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Results 
Patients with a DTAA, alone or with coexistent ATAA, had significantly 
more hypertension (80.6% vs. 61.8%, p<.001) and a higher burden of 
atherosclerotic disease ( 86.7% vs. 7.5%, p<.001) ) and were more likely to be 
female (59.3% vs. 29.5%, P<.001). Conversely, patients with isolated ATAA were 
significantly younger (average age 59.5 vs. 71, p<.001), and contained almost 
every case of overt genetically-triggered TAA. Patients with isolated DTAA were 
demographically indistinguishable from patients with combined ATAA and DTAA. 
In follow up, patients with isolated DTAA, or with ATAA and DTAA, experienced 
significantly more aortic events (aortic dissection/rupture) and had higher 
mortality than patients with isolated ATAA.  
 
Conclusions 
Based on patient characteristics and outcomes, subtypes of TAA emerge. 
DTAA with or without associated ATAA or AAA appears to be a disease more 
highly associated with atherosclerosis, hypertension, and advanced age. In 
contrast, isolated ATAA appears to be a clinically distinct entity with a higher 
burden of genetically triggered disease. These data have important implications 
for familial screening recommendations for TAA.  
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 1 
INTRODUCTION 
The aorta is the largest artery, whose function is to carry oxygenated 
blood to all the different parts of the body via the systemic circulation. 
Anatomically, the aorta can be divided into the thoracic aorta, which runs from 
the left ventricle to the diaphragm, and the abdominal aorta, extending from the 
diaphragm to the aortic bifurcation (split of the aorta into the left and right 
common iliac arteries at the level of the fourth lumbar vertebrae). Another 
approach to dividing the aorta considers direction of blood flow. In this scheme, 
the aorta starts at the left ventricle as the ascending aorta and travels superiorly. 
The ascending aorta eventually becomes continuous with the aortic arch, which 
begins at the level of upper border of the second sternocostal articulation where 
it subsequently makes a hairpin turn and passes downward at the level of the 
fourth thoracic vertebra becoming continuous with the descending aorta. 
 
Aortic Nomenclature 
The first portion of the aorta is called the aortic root, located just distal to 
the aortic valve (Figure 1). The aortic root contains three small pockets, situated 
between the cusps of the tricuspid aortic valve and the wall of the ascending 
aorta, known as the aortic sinuses (sinuses of Valsalva). The left sinus contains 
the origin of the left coronary artery, while the right sinus contains the origin of 
the right coronary artery; these two vessels provide blood to the walls of the 
heart. The posterior aortic sinus does not give rise to a coronary artery1.  
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 The aortic arch gives rises to three major branches: starting proximally 
and extending distally is the brachicephalic trunk, which nourishes the right head 
and neck regions along with the right arm and chest wall; the left common carotid 
and the left subclavian arteries, which supply the left portions of the same 
regions. The thoracic aorta gives rise to several important arteries, namely the 
intercostal and subcostal arteries along with variable branches to the esophagus, 
pericardium, and mediastinum.  
  
Figure 1.  Aortic root anatomy: extending from the aortic valve to the 
ascending aortic arch (Marios et al., 2014).  
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At the lowest levels of the thoracic aorta are the superior phrenic and 
subcostal arteries that supply the diaphragm and the twelfth rib. The abdominal 
aorta gives rise to the renal and middle suprarenal artery, visceral arteries (celiac 
trunk, superior mesenteric artery, and inferior mesenteric artery), lumbar artery, 
and the musculophrenic artery. As mentioned before, the abdominal aorta 
terminates at the bifurcation, draining into the left and right iliac arteries2.  
 
Aortic Structure 
In both mammalian and avian embryological development, the pharyngeal 
arch arteries form the general pattern of the great arteries. Of the various arches, 
the fourth arch becomes the aortic arch in vertebrates, while the third arch 
becomes the brachiocephalic artery/root of the internal carotid. The sixth arch 
adds to the development of the pulmonary arteries. Smooth muscle cells that 
form the aorticopulmonary septum, the structure that separates the aorta and 
pulmonary arteries, are cardiac neural crest cell derived. The contribution of 
cardiac neural crest cells to the walls of the aorta is highly unusual, and specific 
to this section of the body3.  
The aorta, displayed in Figure 2, is a distensible artery with elastic 
properties that are reflected in its structure. The aorta has three layers: the tunica 
externa, tunica media, and tunica intima. The tunica intima is the innermost layer 
of the aorta; it consists of one layer of endothelial cells that are in direct contact 
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with flowing blood. The second component of the vascular wall, the tunica media, 
is composed of smooth muscle and elastic tissue. Given its biological function,  
the elastic component of the aorta is very considerable; the fundamental unit of  
 
 
 
Figure 2.  General Aortic Anatomy  
Figure 2.  General Aortic Anatomy: Progressing from the aortic root 
extending to the abdominal aorta (Murillo et al., 2012). 
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the media is the elastic lamella, which is an organized distribution of elastic 
fibers, type III collagen, proteoglycans, and glycosoaminoglycans. The elastic 
matrix present within the tunica media has a dominant role in the mechanical 
properties of the aorta, allowing it to distend in order to accommodate the large 
blood volume it receives from the heart during systole. The tunica externa 
(adventitia) is the outermost layer of the aorta; it consists of mainly collagen and 
is supported by the external elastic lamina, whose function is to anchor the aorta 
to nearby organs. The thickness of the aorta necessitates a complex network of 
vasa vasorum running through the adventitia, which nourishes the aortic wall 
itself. The aorta is innervated by the autonomic nervous system that uses 
baroreceptors and chemoreceptors to send information on carbon dioxide levels, 
blood pH, and blood pressure to the medulla oblongata in the brain4.   
Blood flow is pulsatile in nature; this pulse wave is propagated along the 
aorta when eventually it is reflected back to the aortic valve. The waves push 
back on the valve, and in the aortic pressure curve this creates a dicrotic notch.  
Increasing age leads to stiffening of the aorta, and as a result the pulse is 
propagated faster leading to a quicker rebound to the semilunar valve, indicating 
higher blood pressure. Many pathologies and diseases are associated with a 
stiffened aorta; as a result pulse wave velocity is considered an independent 
indicator of hypertension2. The aorta also has the highest mean arterial pressure 
(MAP) in the cardiovascular system. MAP tapers distally as blood progresses 
from the aorta towards the arteries and arterioles. Distention of the aorta has 
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very important physiological function because as it receives the cardiac output, 
its elastic properties allow it to expand to some extent and accommodate the 
large volume of blood. This stretching provides the necessary potential energy to 
maintain blood pressure during diastole. The energy is transferred as the aorta 
passively contracts in a physiological process known as the Windkessel effect of 
the great arteries2. There are significant biomechanical implications of the 
Windkessel effect that help ensure proper blood circulation; the elastic recoil of 
the aorta helps smooth out the pulses created by the heart, this creates less 
turbulent blood flow as MAP decreases distally, creating optimum conditions for 
exchange of gases and nutrients in tissue5.  
 
Aortic Pathologies 
Given the prominent role of the aorta in the cardiovascular system, 
diseases of the aorta are clinically important and often require emergency 
medical attention. Aortic diseases can either be lifestyle- or genetic-associated. 
Aortic Coarctation (CoA) is a congenital condition that leads to narrowing of the 
aorta. This condition can have significant affects in newborns and young children 
depending on how severely the aorta narrows. Typically, CoA occurs distal to the 
left subclavian artery resulting in arterial hypertension in the upper extremities 
and hypotension in lower extremities2. Left ventricular function is compromised 
when, as a result of the arterial hypertension, the ventricle is forced to generate 
higher pressure than normal. If the heart is unable to generate sufficient pressure 
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to provide high enough blood flow through the occluded aorta, body wide 
perfusion becomes inadequate. Another common aortic pathology is aortic 
stenosis (AS), a condition where the aortic valve is abnormal causing obstruction 
to left ventricular outflow. When mild AS is asymptomatic, but when severe can 
lead to congestive heart failure (CHF)6.   
Aortic aneurysm is one of the most common aortic pathologies. It is 
defined as a dilation of a segment of the aorta that, if left untreated, has the 
propensity to expand and eventually rupture. To be considered an aneurysm, the 
dilation must exceed normal luminal diameter by at least 50% greater than 
expected for an unaffected person of similar characteristics6. Aneurysms are 
usually described by size, location, morphology, and cause. Imaging, usually via 
echocardiogram, is used to determine the cross-sectional diameter of the 
proximal aorta. Morphologically, aortic aneurysms can be described as either 
fusiform or saccular3. Fusiform aneurysms extend symmetrically around the 
entire circumference of the aorta, while saccular aneurysms present focally in 
one location. Frequently, aortic aneurysms present in one of two locations, either 
in the thoracic cavity as a Thoracic Aortic Aneurysm (TAA), or in the abdominal 
cavity as an Abdominal Aortic Aneurysm (AAA)2. 
Aortic aneurysm is a life-threatening disorder due to the predisposition of 
the enlarged arterial segment to a high risk of tear or “dissection”; Aortic 
dissection (AoD) is a clinical event with a high mortality and morbidity7. The 
identification of etiologic factors in the pathogenesis of TAA has been determined 
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primarily through clinical observations in aneurysm or dissection registry patients. 
A primary source of this information is the International Registry of Aortic 
Dissection (IRAD) as well as through observations in large groups of aneurysm 
patients. IRAD has delineated several important clinical factors that have been 
shown to contribute to AoD, including: hypertension, atherosclerosis, male sex, 
and advanced age2. Many of these factors mirror risk factors delineated for 
coronary artery disease, stroke, and abdominal aortic aneurysm (AAA)7.   
AAA is defined by an increase in size of the abdominal aorta to >3.0 cm in 
diameter8. This disease has an incidence of between 3%–9% of men 50 and 
older9. AAA is the tenth most common cause of mortality in the western world, 
accounting for 2% of deaths. Generally, AAA is followed until  <5.5cm via 
periodic ultrasound surveillance, at which point elective surgery is undertaken to 
correct the malady. Surgery is the most common form of treatment for AAA, 
however surgical intervention is associated with high morbidity and mortality, and 
catheter-based approaches are becoming feasible for routine repair11. Risk for 
AAA is approximately four times as high in men as among women, individuals 
with family history are also four times at higher risk for AAA. The strongest 
modifiable cause of AAA is smoking, while hypertension, cholesterol, and obesity 
are less prominent but still important contributors to AAA10. 
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Genetic Causes of Aortic Disease 
TAA is a consequence of cystic medial degeneration, which is represented 
by smooth muscle cell hyperplasia, elastin degeneration, and excess collagen 
deposition resulting in a weakened and stiff aortic wall12. Several genetic 
conditions with smooth muscle pathologies have become associated with the 
development of TAA. These include congenital defects like the aneurysm 
associated with BAV, as well as connective tissue disorders like Ehlers-Danlos 
syndrome, Marfan syndrome, and Loeys-Dietz syndrome6. 
Ehlers-Danlos syndrome (EDS) is an inherited connective tissue disorder 
caused by defective structure, processing, or production of collagen and/or 
collagen associated proteins. EDS has an incidence of approximately 1 per 5000 
births, and has no ethnic, racial, or geographic biases2. There are several 
different types of EDS, with a variety of different phenotypes and clinical 
presentations.  Classical EDS patients typically have soft/hypertensible skin, 
easy bruising, atrophic scars, hypermobile joints, and varicose veins although 
these patients are not at risk of aneurysm or dissection13. In contrast, type IV or 
vascular EDS has many of the same skin and joint phenotypes as classical EDS 
however it has also been implicated with severe cardiovascular pathologies, 
namely dilation and/or rupture of the aorta. Mutations associated with Type IV 
EDS are located in the COL3A1 gene. Interestingly, dissection and rupture in 
Type IV EDS patients are often not preceded by aortic dilation13.  
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Marfan syndrome (MFS) is an autosomal dominant disorder first described 
in 1896 by French pediatrician Antoine Bernard-Jean Marfan12. The prevalence 
of Marfan syndrome is between .5–1 cases per 10,000, it affects males and 
females equally and has no ethnic or geographical biases. Diagnosis for MFS is 
made according to the clinical criteria of “Ghent Nosology”14. The current Ghent 
Nosology relies on the presence of clinical and genetic features: aortic root 
aneurysm, ectopia lentis, and physical features as well as mutational analysis of 
the FBN1 gene to determine MFS diagnosis15. Specialists often rely on several 
stereotypical but not universal clinical features to confirm an MFS diagnosis. 
Characteristically patients show an elongation and narrowness of the long bones 
leading to tall stature and long thin limbs, low skeletal muscle mass, scoliosis, 
and pectus excavatum, and arachnodactyly. Ocular degeneration is also a 
significant problem in MFS patients, as 60% develop ectopia lentis or dislocation 
of the lens of the eye. This clinical manifestation may indicate rapid MFS eye 
disease progression; retinal detachment and glaucoma can also occur15.  
The most dangerous clinical manifestation of MFS is aortic root aneurysm 
and the proceeding ascending aortic dissection and/or rupture. At the age of 18 
over 99% of MFS patients exhibit some sort of aortic dilation. Overall, if 
prophylactic surgery is not undertaken the lifetime risk for aortic dissections 
stands at over 75%.  Size of the proximal aorta is generally considered the most 
reliable index for relative risk for rupture and dissection. Generally if the aortic 
diameter is >5 cm surgical intervention is recommended. For MFS patients 
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regular monitoring of aortic growth is required, and generally a growth rate of >.5 
cm per year is strongly indicative of increased risk of dissection, and another 
indication for surgery. Given the location of most aortic dilations, transthoracic 
echocardiography (TTE) is adequate for visualization, monitoring, and 
measurement of the aortic root in most MFS patients16, although periodic 
surveillance of the entire aorta by CTA or MRA is warranted every five years. 
MFS is a result of mutations in the FBN1 gene that encodes the fibrillin-1 
glycoprotein. The FBN1 gene contains 65 exons spanning 235 kb of DNA on 
chromosome 15q21.1 [10,11]12.  Fibrillin-1 is deposited in the extracellular matrix 
microfibrils including but not limited to the periphery of the elastic fibers in the 
tunica media of the ascending aorta. Functionally, fibrillin-1 regulates 
transforming growth factor-β (TGFβ). Usually fibrillin-1 functions to inhibit TGFβ 
activity, however in MFS patients with a paucity of fibrillin-1, TGF-β levels are 
elevated16.  
Loeys-Dietz (LDS) is an autosomal-dominant connective tissue disorder. It 
is characterized by aortic aneurysm, arterial tortuosity, hypertelorism, bifid uvula, 
and cleft palate. Mutations in the transforming growth factor-β type II receptor 
(TGFBR2), transforming growth factor type I (TGFBR1), decapentaplegic 
homolog 3 (SMAD3), and transforming growth factor β-2 (TGFB2) can all cause 
LDS. All of these genetic mutations show altered TGF-β signaling leading to the 
cardiovascular, craniofacial, cutaneous, and skeletal pathologies of LDS17. The 
most significant pathology is widespread arterial involvement, leading to arterial 
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tortuosity, aneurysm, and dissection. Treatment for LDS includes regular imaging 
surveillance and prophylactic surgery. Other vascular management strategies 
include the use of blood pressure lowering medications, more specifically β-
adrenergic blockers and angiotensin receptor type 2 receptor blockers (ARBs) 
therapy to reduce hemodynamic stress on vasculature17. Bicuspid aortic valve 
(BAV) is a congenital cardiac defect, with an incidence of .5%–2% in humans. 
Figure 3 shows BAV pathology, which results when two of the commissures. 
Commissure fusion results in the improper opening and closure of the valve,   
 
Figure 3. The leaflet are defined as commissures (Right, Left, and Non. A, Left-
Right BAV. B. Right-Non BAV. C, Non-Left BAV, Left-Right BAV with two equal sized 
leaflets. E, Left-Right true BAV. F, Left-Right BAV with incomplete raphe (Michelena et 
al., 2014). 
A	   B	   C	  
D	   E	   F	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changing hemodynamics and contributing to proximal aortic pathology.  BAV has 
several variants that depend on the presence or absence of various amounts of 
redundant valvular tissue. Valves with less redundant tissue develop stenosis, 
whereas valves with more redundant tissue develop incompetence18. Bicuspid 
aortopathy is defined by dilation of any part of the aorta proximal to the aortic root 
and extending to the aortic arch. 50% of individuals with BAV have dilation in the 
ascending aorta.  
Abnormalities of the aortic tunica media are the primary reason for dilation 
of the proximal ascending aorta and changes in the media are present with or 
without the misshapen valve. However, ascending aortic pathology is seen as an 
expression of the genetic basis of BAV. Inadequate production of the fibrillin-1 
gene during embryogenesis may contribute to both BAV and a weakened aortic 
wall16. 
 
Anatomic Variation in Aneurysm 
Initial evidence for divergent etiologies between anatomic categories of 
aortic aneurysm derives from comparison between TAAs and AAAs. 
Investigators in Olmstead County, Minnesota, first noted variation in the 
incidence of TAA vs. AAA over the same observation period leading the authors 
to speculate that causative factors may be different. Since these initial studies, 
the divergence of etiologic factors has been more convincingly demonstrated. 
 Using a cohort of 341 patients referred for aneurysm surgery, Ito and 
coworkers used several descriptive variables to delineate differences in health 
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profiles for patients with TAA and AAA. Ito et al. elegantly demonstrated a clear 
enrichment of dyslipidemia, atherosclerosis, and coronary artery disease in 
patients with AAA versus a combinatorial group of TAA patients20. In contrast 
patients with AAA had significantly less incidence of hypertension compared to 
patients with TAA. These findings demonstrate that despite similar morphological 
appearance of aneurysms, pathological causes of TAA and AAA are different20. 
A major difference between this project and Ito’s work is classification of location 
and morphology in comparison groups.  Ito et al. does not differentiate between 
ascending or descending TAAs. Using the clinical methodology set forth by Ito 
and coworkers, this project was set out to expand upon the differences in clinical 
characteristics in patients with ascending, descending, and combinatorial TAA.  
In contrast to AAA, a distinct feature of TAA is the strong influence of 
heritable factors including single gene disorders with nearly complete 
penetrance. In some of these conditions, TAA and resultant AoD often occur in 
the absence of other risk factors. Patients with these conditions tend to be 
younger and exhibit extracardiac manifestations of connective tissue disease 
(CTD) often caused by loss-of-function mutations in genes encoding the 
members of the canonical TGF-β signaling cascade, such as in the Marfan 
syndrome (MFS)21. Genetically triggered TAA is not limited to these groups, as 
multiple conditions mutations in various components of the smooth muscle 
contractile apparatus in patients without features of CTD. Similarly, heritable 
influences are also thought to play a prominent role in the etiology of TAA 
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associated with Bicuspid Aortic Valve (BAV)22. 
While TAAs are often grouped together, there is ample evidence that not 
all TAAs behave similarly. In a landmark study, Coady and coworkers reported 
survival differences among 230 patients with TAA23. Coady et al. attempted to set 
different surgical recommendations for ascending thoracic aorta aneurysms 
(ATAA) and descending thoracic aortic aneurysms (DTAA). Coady and 
colleagues studied mean aneurysm size, growth rate, complication rate, 
operative mortality, preoperative morbidity, and long-term survival in their patient 
groups. Using these data, they were able to demonstrate that survival was 
significantly lower for patients with DTAA compared to those with ATAA. 
Aneurysmal size was a meaningful risk factor for complications (acute dissection 
or rupture) and was a divergent value in ATAA vs. DTAA. As a result, different 
“hinge” points were set as a basis for divergent surgical repair recommendations 
for ATAAs vs. DTAAs23.  This project by Coady et al. further demonstrated the 
pathological differences in TAA. Given the presence of differing growth rates and 
aortic sizes, and subsequently differences in survival it can be hypothesized that 
etiology in ATAA vs. DTAA is markedly different.  
Similarly, analyses in International Registry of Acute Aortic Dissection 
(IRAD) demonstrate major differences between aortic aneurysm size in patients 
presenting with Stanford Type A dissection (involving the ascending aorta or 
arch) and Type B dissection (distal to the left subclavian artery). Various studies 
submitted to IRAD demonstrate divergent clinical behavior for Type A and Type 
	  	  
 16 
B dissection. Aortic dissection is pathologically characterized by the development 
of an intimal flap in the tunica media of the aortic wall, creating a false lumen 
within the tunica media. Often this tear can spread in anterograde or retrograde  
directions and can involve coronaries and iliac arteries, causing mal-perfusion 
syndrome by static or dynamic obstruction. Intramural hematoma and plaque  
rupture/ulceration are often precursors of the aortic plaque that develops into the 
dissection13. 
Acute dissection of the ascending aorta has rates of mortality of 1% to 2% 
per hour after onset of symptoms. Risks of ascending AoD are: contained rupture 
into pericardium, involvement of coronary arteries leading to myocardial 
infarction, or dissection compromising brain perfusion.  Type A dissection is a 
surgical emergency and even with surgical intervention carries a mortality rate of 
10% in 24 hours, 13% in one week, and 20% within a month24. The most 
common events subsequent to type A dissection are aortic rupture, visceral 
ischemia, and cardiac tamponade (build up of fluid between myocardium and 
pericardium)25. Surgically, the most common course of action is to repair the tear 
primarily by replacing the aortic root and often the aortic valve as well. 
Unfortunately, only in 10% of cases do operated type A dissections have post-
operative false lumen obliteration24.  
Acute aortic dissection of the descending aorta is less lethal than type A 
dissection: these can be compared in Figure 4. Patients with uncomplicated type 
B dissection typically have a 30-day mortality rate of 10%. However those who 
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develop complications (renal failure, visceral ischemia, rupture, etc.) often require 
emergency surgery and as a result their 30-day mortality raises to 20%. 
Dissection of the descending aorta is also common among chronic crack cocaine 
users13.    
Various studies within IRAD show notable differences in risk factors for 
dissection pathology and substantive differences in critical proximal branch 
vessels and anatomic distribution patient outcomes.  This information should not 
be surprising considering the hemodynamic, structural, and developmental 
differences between these portions of the thoracic aorta.  
 Despite multiple observations of clinical discrepancy between ATAAs and 
DTAAs there is limited analysis of comparative patient characteristics with these 
conditions. Experimentally, TAA is often conflated as a homogeneous disease, 
however differences in aneurysm size at time of aortic events and even 
differences in distribution of AoD patterns suggest divergent etiologies amongst 
Figure 4. Normal Aorta, Type A AoD, Type B AoD (Nienaber et al., 2003) 
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subclasses of TAA. We therefore decided to evaluate the differences in patient 
characteristics and outcomes in three groups of patients: those with isolated 
ATAAs, DTAAs, and mixed aneurysm (both ATAAs and DTAAs). 
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METHODS 
Patients diagnosed with thoracic aortic diseases at Massachusetts 
General Hospital are prospectively registered in our institutional Thoracic Aortic 
Center Database, which records baseline patient characteristics, detailed 
information on aortic interventions, and follow-up outcomes. This database was 
queried for “thoracic aortic aneurysm” which yielded 3,247 adult patients (age ≥ 
17 years) who were diagnosed as having thoracic aortic aneurysm from July 
1992 through August 2013. A retrospective review was undertaken for these 
patients including systematic reviews of computed tomography (CT) or magnetic 
resonance imaging (MRI) of the aorta performed at baseline. Diameters of aorta 
were measured systematically at ascending, arch, descending thoracic and 
thoracoabdominal segments, and they were recorded for analyses if the 
diameters were 35mm or greater. Patients with maximal aortic diameter of 35mm 
or greater were included in this study. Exclusion criteria included no aortic 
segment greater than 35 mm and evidence of dissection or intramural 
hematoma. These data are demonstrated pictorially in Figure 5.  
 Patient groups were assigned by the location of maximal aortic dimension. 
The ascending thoracic aorta was defined between the aortic valve and the right 
brachiocephalic artery. ATAA patients have an ascending aortic dimension >35 
mm with no other segment >35 mm. The descending aorta was defined from the 
origin of the left subclavian artery to the diaphragm. DTAA patients had a 
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descending aortic dimension >35mm with no other segment >35 mm. Patients  
with ascending thoracic aortic dimension >35mm and a descending aortic 
dimension >35mm were placed in Group C.  
 After this the patient population was reduced to 918 patients, with 677 
patients in the ATAA category, 96 patients in the DTAA category, and 145 
patients in the mTAA category. Using the medical record numbers (MRN) of 
these patients a targeted search was done in the Research Patient Data Registry 
(RPDR). This database contains all visit information on patients at Brigham and 
Women’s’ and Massachusetts General Hospitals. A query for laboratory results 
and patient diagnosis’ yielded the information used for additional baseline 
statistics. However, it was impossible to obtain all necessary information from the 
RPDR search. As a result, a chart review on all patients was undertaken to 
gather data for unsearchable clinical variables. This chart review used OnCall 
and Queriable Patient Inference Dossier (QPID) to retrieve specific information 
on patients queried. After all relevant information was obtained statistical analysis 
was done using two software programs, Statistical Analysis Software (SAS) and 
Microsoft Excel.  
Definitions and Statistical Analysis 
The primary endpoint was defined as a composite of adverse aortic events 
that include acute AD, aortic rupture and sudden death not explained by causes 
other than aortic diseases. Diagnoses of aortic rupture or dissection were 
confirmed by adequate imaging studies (MRI, CT) or surgical findings. Since the 
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primary aim of this study is to evaluate the natural course of aortic aneurysm, 
patients who underwent elective aortic surgery before the aortic events or who 
died of other causes than aortic disease were regarded as censored at the time 
of such events. 
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3	   
Figure 5.  CTA balloon diagrams and flow data demonstrating patient selection 
process and group dispersal.  
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 RESULTS 
Patient demographics  
 
The study strategy is illustrated in Figure 5. Full aortic imaging was 
available on 918 patients with diverse patterns of TAA without evidence of aortic 
dissection. The total study group was divided based on pattern of aneurysm 
location. The majority of patients (677) had isolated ascending aortic aneurysm 
(ATAA), while 96 patients had isolated descending thoracic aneurysm (DTAA). 
Aneurysm of both the ascending and descending aorta was seen in 145 patients 
(mTAA) (Figure 1). Patient groups were examined for demographics and 
outcomes. Table 1 displays baseline demographics and clinical characteristics 
for all patients. Interestingly, patients with mTAA were almost indistinguishable 
from DTAA, while ATAA patients showed distinct differences from DTAA and 
mTAA in almost all examined categories. Compared to DTAA, patients with 
ATAA were younger (62.1 ± 13 vs. 71 ± 12 years, p<0.001), and less likely to 
have diabetes mellitus (5.1% vs. 13.2%, p<0.001), hypertension (61.8% vs. 
80.6%, p<0.001), and a history of smoking (45.9% vs. 75.2%, p<0.001). These 
differences were reflected in significantly higher rates of antihypertensive use in 
patients with DTAA; specifically of calcium channel blockers (CCB), angiotensin 
converting enzyme inhibitors (ACEi), and diuretics (Table 1). History of coronary 
artery bypass surgery was less common in ATAA than in patients with DTAA or 
mTAA (8.0% vs. 15.4% or 17.5%, both p<0.05).  Table 1s contains the analysis 
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of variance (ANOVA) for age, BSA, and BMI. These data show significance when 
comparing all three cohorts ATAA, DTAA, and mTAA to one another 
We analyzed the distribution of aortic aneurysms secondary to overtly 
identifiable genetic influence including bicuspid aortic valve associated TAA 
(BAV) and transforming growth factor-β vasculopathies (TGFβVs), such as 
Marfan syndrome (MFS) or Loeys-Dietz syndrome (LDS). These conditions were 
markedly enriched in the ATAA group versus either DTAA or mTAA (BAV, 30.3% 
vs. 0% or 3.5%, both p<0.001) (TGFβVs, 3.54% vs. 0% or 1.4%, both p<0.001). 
It has been hypothesized that patients with genetically-triggered aortic disease 
may be identified earlier than those with sporadic disease based on either 
anthropomorphic manifestations (i.e. MFS) or physical exam findings such as 
murmur (i.e. BAV). To determine if the observed demographic differences in 
patient groups were attributable to the influence of overtly identifiable genetically-
triggered disease and early referral we reanalyzed the groups excluding the 
diagnosis of BAV and TGFβVs. Interestingly, differences in age, as well as in 
rates of diabetes mellitus, hypertension, and CABG remained statistically 
significant after censor of these diagnoses (Table 2). To further analyze this 
issue we examined the impetus for aortic care referral (Figure 6). The dominant 
reason for referral for all study groups was the size of aneurysm on radiographic 
examination obtained for a different reason (ATAA 89.5% vs. DTAA 96.7% vs. 
mTAA 99.3%). There were more patients in the ATAA group referred for 
suspicion of genetic diagnosis (ATAA 5.5% vs. DTAA 3.3% vs. mTAA 0.7%), 
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although these differences were not statistically significant. Table 2s contains the 
analysis of variance (ANOVA) for age, BSA, and BMI. These data show 
significance when comparing all three cohorts ATAA, DTAA, and mTAA to one 
another.  
 
Imaging Characteristics  
 
We next examined imaging data for aneurysm characteristics to determine 
whether distinctions could be made between groups (Table 3). Imaging 
characteristics of aneurysms were markedly different between the study groups 
with dramatic increases in evidence of atherosclerosis within the aneurysm in 
DTAA and mTAA groups versus ATAA (86.7% and 83.5% vs. 7.5%, p<0.001), 
ulcer-like projections (9.1% and 6.9% vs. 0.2%, p<0.001), and calcifications 
(80.6% and 72.6% vs. 6.7%, p<0.001) (Table 3). In general, maximal aortic 
diameters were larger in patients with DTAA and mTAA than in ATAA (Figure 7). 
To determine if the imaging and demographic differences we have observed 
were more closely related to aneurysm size instead of anatomic location, we 
analyzed variables in quartiles groups on the basis of aneurysm size. The 
observed demographic differences (Table 1) were found to persist regardless of 
aneurysm size quartile (Table 4) 	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Table 1.   Baseline demographics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Legend: BMI (Body Mass Index) (kg/m2), BSA (Body Surface Area) (Dubois 
Formula) *ATAA n=542, DTAA n=69, mTAA n=74. DM (Diabetes mellitus). HTN 
(Hypertension). BB (Beta-Blocker). CCB (Calcium Channel Blocker). ACE (Angiotension 
Converting Enzyme Inhibitor). ARB (Angiotensin Receptor Blocker). BAV (Bicuspid 
Aortic Valve). TGFβVs (Transforming Growth Factor β Vasculopathies, including Marfan 
and Loeys-Dietz Syndrome). CABG (Coronary Artery Bypass Grafting) **ATAA n=675, 
DTAA n=96, mTAA n=144. 
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Table 1s.  Anovas for baseline demographics  
 
 
 
 
 
 
 
	  	  
 28 
Table 2.   Baseline demographics after removal of genetically triggered disease  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Legend: BMI (Body Mass Index) (kg/m2), BSA (Body Surface Area) BSA (Dubois 
Formula) *ATAA n=525, DTAA n=71, mTAA n=88. DM (Diabetes mellitus ). HTN 
(Hypertension). BB (Beta-Blocker). CCB (Calcium Channel Blocker). ACE (Angiotension 
Converting Enzyme Inhibitor). ARB (Angiotensin Receptor Blocker). BAV (Bicuspid 
Aortic Valve). CABG (Coronary Artery Bypass Grafting) **ATAA n=675, DTAA n=96, 
mTAA n=144. 
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Table 2s.  Anovas for baseline demographics after removal of genetically triggered 
disease 
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ATAA# DTAA# mTAA#
 ATAA (n=659) DTAA (n=93) mTAA (n=145) 
Size of aneurysm on film 587 (89%) 90 (96.7%) 144 (99.3%) 
Dyspnea 10 (1.5%) 0 0 
Angina 5 (.75%) 0 0  
Murmur   21 (3.2%) 0 0 
Genetic 36 (5.5%) 3 (3.3%) 1(.7%) 
Figure 6  Referral Diagram with representative pie graphs 
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Table 3.  Imaging characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3s.  Anova for imaging characteristics 
 
 
 
 
 
 
 
 
 
Figure 7   Aneurysm Histogram 
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Table 4.  Size cohort tables 
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Table 5. Event and Surgery Distribution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Legend: *Event percentage (ATAA=677, DTAA=96, mTAA=145), AVR (Aortic 
Valve Repair). TAAA (Thoracic Endovascular Aortic Aneurysm Repair). TEVAR 
(Thoracoabdominal Aortic Aneurysm Surgery).  
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Event and Surgery Description  
Patients with TAA are known to express an increased risk of aortic surgery 
and adverse aortic events. We analyzed study groups with respect to surgical 
utilization, adverse aortic events, and overall mortality. Surgery was common in 
all study groups but enriched in DTAA and mTAA groups with approximately half 
of these patients having an aortic procedure within 5 years (Table 5 and Figure 
4A). Surgical procedures are documented in Table 6. All cause mortality was 
similarly enriched in patients with DTAA and mTAA compared to ATAA groups 
(Figure 8B). 
Overall (and one year) adverse aortic events are illustrated in Figure 8C & 
D. Patients with DTAA and mTAA distributions had a significantly higher 
percentage of aortic events than ATAA patients. The nature of aortic events 
mirrored the pattern of aneurysmal distribution with the ATAA group experiencing 
exclusively Type A AoD and the DTAA group experiencing exclusively Type B 
AoD (Table 5). Interestingly, mTAA events were exclusively Type B despite the 
presence of both ascending and descending aortic aneurysm. The aortic event 
subtypes were different between groups with fewer aortic ruptures in the ATAA 
group (ATAA 14.3% vs. DTAA 50% vs. mTAA 88.9%) and the only mortality 
occurring with the mTAA group. Figure 10 summarizes the univariable and 
multivariable risk factor analyses of adverse aortic events. On multivariable 
analyses, maximal aortic diameter (HR 1.11; 95% CI 1.06–1.15; p<0.001) and 
atherosclerosis (HR, 6.6; 95% CI, 2.3–18.7; p<0.001) emerged as significant 
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independent predictors of aortic events. Freedom from aortic events for these 
factors is depicted in Figure 9.  
 
Table 6. Surgical Procedures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Legend:  TAAA (Thoracoabdominal Aortic Aneurysm Surgery). TEVAR  
(Thoracic Endovascular Aortic Aneurysm Repair). VSRR (Valve-sparing and non valve-
sparing). MVR (Mitral Valve Repair). 
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Figure 8. Event Kaplan-Meier curves 
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Figure 9.  Kaplan-Meier curves and univariable/multivariable analysis  
 
 
 
 
 
 
 
 
Figure 10. Univariable and Multivariable Anaylsis 
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DISCUSSION 	  
There are gaps in the literature and understanding regarding the etiology 
of thoracic aortic aneurysm. This study endeavored to expand upon relevant 
research by analyzing differences in patient populations with ascending aortic 
aneurysm (ATAA), descending aortic aneurysm (DTAA), and mixed aortic 
aneurysm (mTAA). Table 1 provides the general breakdown of patient’s 
characteristics for the three different aneurysm groups. It was demonstrated that 
DTAA patients are older, more hypertensive, and less likely to have genetic 
conditions than their ATAA counterparts. These data suggest that genetic 
predispositions are partially responsible for aneurysm in the ascending thoracic 
aorta atherosclerotic burden is suggestive of possible aneurysm formation in the 
descending thoracic aorta.  
 
Etiology of ATAA 
Congenital conditions such as BAV and connective tissue disorders like 
Marfan syndrome have long been known to contribute to the natural history of 
ATAA.  Aortic aneurysm progressing to dissection or rupture is often the main 
cause of mortality in these patients.  Our research relied on the presence of 
genetically triggered disorder in the ATAA cohort to confirm the distinct etiological 
basis of aneurysm. We found that TGFβv’s were almost totally enriched in the 
ATAA and mTAA groups, this evidence was corroborated by Januzzi et al. who 
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observed high numbers of Marfan patients in Type A AoD vs. Type B AoD21. To 
further confirm the role of genetics in ATAA we investigated the presence of BAV 
in each cohort; results in Table 1 show that BAV is heavily enriched in the ATAA 
cohort vs. the DTAA cohort (30.3% vs. 0%, p<.001) and to a lesser extent the 
mTAA cohort vs. the DTAA cohort (3.5% vs. 0%, p<.001).  Reported data by 
Nkomo and colleagues supports these results by suggesting that BAV is related 
to proximal aortic dilation26. Using these studies and the known role of the FBN1 
genetic locus in cystic medial generation, we were able to speculate on the 
pronounced role of genetics in ATAA. 
 
Etiology of DTAA 
Although the direct role of genetics in DTAA has been researched, its 
precise role has proven hard to confirm. It seems more likely that DTAA is 
concomitant with causes either influenced genetics, such as propensity to 
develop atherosclerosis, or causes that exacerbate that progression of this 
phenotype, such as old age. The atherosclerotic profile of the Thoracic Aortic 
Clinic (TAC) cohort was collected through evaluation of imaging data on several 
identifiable characteristics available in Table 3: atherosclerosis, ulcer-like 
projections (ULP), and calcification. These data showed atherosclerotic burden 
heavily skewed in DTAA and mTAA patient groups. Significantly less patients in 
the ATAA cohort were identified as atherosclerotic on imaging (p<.001), 
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measurements for ULP and calcification showed a similar trend, skewing heavily 
towards the DTAA and mTAA cohorts (Table 3). These data confirmed a trend 
seen by Ito and colleagues, who set out to examine the atherosclerotic profile 
differences in individuals with TAA vs. AAA. Using a cohort of 343 patients 
(TAA=132, AAA=211), Ito et al., were able to show that Coronary Artery Disease 
(CAD) was heavily enriched in AAA patients (53%) vs. TAA patients (23%)20. 
While the data presented by Ito et al. is extremely valuable our findings suggest 
that the atherosclerotic profiles of TAA patients aren’t homogenous, and the real 
etiological differences come when comparing the ascending and descending 
thoracic aorta. The above is true when considering isolated aneurysm; however, 
our data shows that patients with synchronous aneurysm in the ascending and 
descending aorta (mTAA) more closely resemble DTAA patients in key baseline 
demographics. This is important because cases of synchronous ATAA and DTAA 
can be quite common among aneurysm patients, with our patient-set showing an 
incidence of approximately 15.7%; Chaer et al. and Clouse et al. report similar 
incidences of 23% and 20%27,28. Regardless of mixed or isolated aneurysm 
phenotype, it can be extrapolated that higher levels of atherosclerosis are 
skewed towards men, associated with older age, and attributed to lifestyle factors 
reflected in the clinical characteristics of these patient cohort groups.  
  
	  	  
 42 
Etiology in Aortic Dissection   
Clinicians often consider aortic aneurysm and aortic dissection together, 
with AoD representing a progression of an aneurysmal phenotype, despite 
evidence that these conditions often exist independently of each other. AoD 
patients can present with no previous signs of aneurysm, and via-versa, 
aneurysmal patients often proceed directly to rupture with no sign of previous 
dissection. While almost all analysis relating aortic anatomy and genetic 
predisposition to disease have not considered aneurysm alone, the work of IRAD 
has proven extremely important in posing the necessary questions when 
considering aortic pathology and disease pattern. IRAD’s work in these patient 
groups helped set the precedent for comparison of our results. Table 1 shows 
that when anatomically divided, ATAA and are younger than DTAA/mTAA 
patients (59.5±13.5 vs. 71±11.75 and 73.7±8.88, p<.001) and less hypertensive 
(56.4 % vs. 82.3% and 80%, p<.001). Likewise, Hagan and coworkers performed  
an analysis comparing clinical characteristics in Type A AoD and Type B AoD 
patients; they demonstrated that Type A AoD patients were younger and less 
hypertensive than their Type B AoD counterparts7  
Atherosclerosis as a Predictor of Aortic Events  
A key attribute of our study was the selection of patients with no previous 
history of aortic dissection, rupture, and/or aortic surgery. This allowed for the 
ascertainment of accurate follow-up in regards to the aforementioned aortic 
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events.  The Kaplan-Meier curves in Figure 8 suggest freedom from adverse 
events is different for ATAA, DTAA, and mTAA both within a year and on a 
longer time scale; with ATAA patient having less events overtime compared to 
DTAA and mTAA. All cause mortality and surgery follow the same course. It is 
interesting to note that while DTAA and mTAA are similar in baseline 
demographics they are distinctly separate when considering adverse aortic 
events, with mTAA falling in between ATAA and DTAA in freedom from aortic 
events (Figure 8A–B). Table 4 details the specific events in the mTAA cohort 
where 88.9% of cases proceeded directly to rupture, it is possible that this 
indicative of severity of pathology and progression of disease phenotype.  
On univariable analysis in a Cox-Regression Analyses hypertension, aneurysm 
location, BAV, atherosclerosis, and maximal aortic diameter are predictors of 
aortic events. In the multivariable analysis only atherosclerosis (HR=6.61) and 
maximal aortic diameter (HR=1.11) survive as predictors of adverse aortic 
events. It was determined that atherosclerosis may influence the presence or 
absence of adverse aortic events in patients with aortic aneurysm. The work of 
Ito and colleagues served as a basis for our rationalization, also based on the 
results in Table 3, that higher atherosclerotic burden is connected to descending 
and mixed aneurysm anatomy20.  
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Conclusion 
In conclusion, our data shows that aneurysm anatomy is reflective of the 
genetic and atherosclerotic history of a particular patient, and as a result 
aneurysm pattern is by association predictive of adverse aortic events. These 
data suggest that therapy for DTAA and mTAA patients should likely be different 
than for ATAA patients. Patients with genetically triggered disease should 
consider β-blockers to halt or reduce aneurysm formation. Whereas, we believe, 
prophylactic administration of anti-cholesterol medications (such as statins) in 
susceptible demographics (ATAA/mTAA) should be considered to prevent the 
progression of aneurysm pathology.   
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